GRTS Gritstone bio Company Short-Term Debt

gritstonebio.com - graphic logo of issuer GRTS

The Gritstone bio, Inc. (GRTS) price chart helps assess the company's potential pricing power within the tumor-fighting segment via its EDGE AI platform. Business efficiency relies on the automation of RNA synthesis using robotics, while product development is based on collaboration with the public healthcare sector. The current metric stands at 0.00, which complements the analysis of the personalized vaccine development strategy.

GRTS Gritstone Bio Short-Term Debt (07/04/2022 - 11/02/2024)

Analytical breakdowns and data insights for company Gritstone bio Inc. (GRTS)

- current quotes and average value forecast:
Price Chart Gritstone Bio|GRTS - Average Forecast Price
- market capitalization data:
Market Value Gritstone bio, Inc.|GRTS - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share Gritstone bio|GRTS - Total Stockholders' Equity|Market Capitalization to Book Value Ratio gritstonebio.com|GRTS - Company Balance Sheet Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Gritstone bio, Inc.|GRTS - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Gritstone Bio|GRTS - Aggregate Debt Obligations|Debts to Book Capitalization Gritstone bio, Inc.|GRTS - Long-Term Debt Volume|Company Short-Term Debt Gritstone bio|Quick Liquidity gritstonebio.com
- earnings and multiples data:
GRTS - Net Income
General company analysis:gritstonebio.com (GRTS)
Flagship merchandise of Gritstone bio, Inc.

The absence of commercial products and high R&D expenses make Gritstone bio, Inc. (GRTS) dependent on external financing to maintain operations. Analyzing the short-term debt snapshot on GURU.Markets, an investor assesses obligations maturing within one year, where a sharp decrease in debt confirms solvency, while its growth signals liquidity risks within the capital structure.

Competitors of Gritstone bio, Inc.

IBRX - Company Short-Term Debt|Short-Term Debt Immunocore Holdings|Janux Pharma (JANX) - Company Short-Term Debt|RCUS (Arcus Corp) - Company Short-Term Debt|Company Short-Term Debt Zymeworks Inc.|Short-Term Debt tangotx.com TNGX|Company Short-Term Debts IOVA|Immatics NV (IMTX) - Short-Term Indebtedness|Xencor Corp - Company Current Liabilities|Compass Therapeutics Corp (CMPX) - Short-Term Debt|REPL: Company Current Liabilities|Company Short-Term Loans and Borrowings LYEL (lyell.com)|IPHA: Company Short-Term Debts|PYXS - Short-Term Debt Volume|Company Short-Term Debt Compugen Ltd|Company Current Liabilities IO Biotech Inc. (IOBT)|Company Short-Term Debt Sutro Biopharma, Inc. (STRO)|Company Current Liabilities minktherapeutics.com INKT|Werewolf Therapeutics, Inc. - Company Current Liabilities|Company Short-Term Debts Immix Biopharma Inc. IMMX|ALXO - Company Short-Term Debt|CUE (Cue Biopharma Inc.) - Company Short-Term Indebtedness|pdsbiotech.com (PDSB) - Company Short-Term Debt|Short-Term Debt Sonnet BioTherapeutics Holdings (SONN)|Company Current Liabilities MAIA|LIMN - Short-Term Indebtedness|Company Current Liabilities LVTX (LAVA Therapeutics N.V.)|Amount of Current Liabilities NXTC|Company Short-Term Debts LPTX (Leap Therapeutics)|Company Short-Term Loans and Borrowings INTS|Sensei Bio - Company Short-Term Debts|Short-Term Debt Theriva Biologics Inc|Kineta Bio (KA) - Company Short-Term Debt|NexImmune Corporation - Company Short-Term Loans and Borrowings|TSBX (Turnstone Biologics Corp) - Company Short-Term Debts|Company Short-Term Debts vaccinex.com|Company Short-Term Debt Harpoon Therapeutics, Inc. (HARP)